{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:23:10Z","timestamp":1790860990290,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81001656"],"award-info":[{"award-number":["81001656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Municipal Science & Technology New Star grant","award":["2010B070"],"award-info":[{"award-number":["2010B070"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.brainresbull.2011.09.016","type":"journal-article","created":{"date-parts":[[2011,9,25]],"date-time":"2011-09-25T19:35:35Z","timestamp":1316979335000},"page":"367-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model"],"prefix":"10.1016","volume":"86","author":[{"given":"Lin-Lin","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Chao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Zu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2011.09.016_bib0005","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.lfs.2004.09.035","article-title":"Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity","volume":"76","author":"Aguiar","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainresbull.2010.01.011","article-title":"Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease","volume":"82","author":"Ambrosi","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-510X(98)00248-2","article-title":"Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle","volume":"160","author":"Araki","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0020","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1074\/jbc.273.3.1269","article-title":"Mammalian RGS proteins: barbarians at the gate","volume":"273","author":"Berman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0025","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1471-4159.2006.03696.x","article-title":"Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats","volume":"96","author":"Carta","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1471-4159.2010.06805.x","article-title":"RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors","volume":"114","author":"Celver","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0035","first-page":"2694","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brainresbull.2011.05.009","article-title":"Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats","volume":"85","author":"Chen","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1474-4422(04)00823-3","article-title":"Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease","volume":"3","author":"Clarke","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0014-4886(91)90095-T","article-title":"Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra","volume":"111","author":"Dawson","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0055","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1523\/JNEUROSCI.17-20-08024.1997","article-title":"Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain","volume":"17","author":"Gold","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0060","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1523\/JNEUROSCI.4223-07.2007","article-title":"RGS9-2 negatively modulated l-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease","volume":"27","author":"Gold","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0065","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.6.10.986","article-title":"Real time quantitative PCR","volume":"6","author":"Heid","year":"1996","journal-title":"Genome Res."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1748-1716.1985.tb07751.x","article-title":"Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats II: the striatum of the rat is heterogeneously organized for rotational behaviour","volume":"125","author":"Herrera-Marschitz","year":"1985","journal-title":"Acta. Physiol. Scand."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0080","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1523\/JNEUROSCI.2840-04.2005","article-title":"D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways","volume":"25","author":"Kovoor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0085","first-page":"148","article-title":"Animal models of tardive dyskinesia\u2014a review","volume":"45","author":"Kulkarni","year":"2001","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3940(94)90957-1","article-title":"Rapid development of D1 and D2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression","volume":"179","author":"LaHoste","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2006.09.019","article-title":"The motor complication syndrome in rats with 6-OHDA lesions treated chronically with l-DOPA: relation to dose and route of administration","volume":"177","author":"Lindgren","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ajmg.b.30796","article-title":"Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia","volume":"150B","author":"Liou","year":"2009","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/exnr.1999.7245","article-title":"Effect of acute l-DOPA pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease","volume":"161","author":"Mandel","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(96)00693-2","article-title":"MK-801 prevents levodopa-induced motor response alterations in Parkinsonian rats","volume":"736","author":"Marin","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0891-0618(95)00064-E","article-title":"Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain","volume":"9","author":"Narang","year":"1995","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/157015911795017029","article-title":"Association between the regulator of G-protein signaling 9 gene and patients with methamphetamine use disorder and schizophrenia","volume":"9","author":"Okahisa","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0135","series-title":"The Rat Brain in Stereotatic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(85)90634-X","article-title":"[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson\u2018s disease","volume":"114","author":"Pimoule","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0150","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1523\/JNEUROSCI.19-06-02016.1999","article-title":"Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene","volume":"19","author":"Rahman","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0155","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0896-6273(03)00321-0","article-title":"RGS9 modulates dopamine signaling in the basal ganglia","volume":"38","author":"Rahman","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0160","first-page":"1484","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N. Engl","volume":"342","author":"Rascol","year":"2000","journal-title":"J. Med."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(91)90554-9","article-title":"A post-mortem study on striatal dopamine receptors in Parkinson\u2018s disease","volume":"556","author":"Rinne","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brainresbull.2010.06.004","article-title":"Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism","volume":"82","author":"Roghani","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0175","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.biochem.69.1.795","article-title":"GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins","volume":"69","author":"Ross","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0180","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-3565(25)20012-X","article-title":"Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice","volume":"252","author":"Rubinstein","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0185","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0190","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(01)01234-3","article-title":"Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease","volume":"50","author":"Tekumalla","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0195","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1789.2004.00559.x","article-title":"Hypertrophy of medial globus pallidus and substantia nigra reticulate in 6-hydroxydopamine-lesioned rats treated with l-DOPA: implication for l-DOPA-induced dyskinesia in Parkinson's disease","volume":"24","author":"Tomiyama","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0205","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.0953-816x.2001.01743.x","article-title":"Persistent changes in striatal gene expression induced by long-term l-DOPA treatment in a rat model of Parkinson's disease","volume":"14","author":"Westin","year":"2001","journal-title":"Eur. J. Neuorsci."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2010.05.068","article-title":"Decreased RGS9 protein level in the striatum of rodents undergoing MPTP or 6-OHDA neurotoxicity","volume":"479","author":"Yin","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease","volume":"144","author":"Yuan","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0220","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.2232594100","article-title":"Essential role for RGS9 in opiate action","volume":"100","author":"Zachariou","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainresbull.2011.09.016_bib0225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0006-8993(88)90264-8","article-title":"Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage","volume":"461","author":"Zhang","year":"1988","journal-title":"Brain Res."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923011002899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923011002899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:13:04Z","timestamp":1759781584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923011002899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":45,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0361923011002899"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2011.09.016","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2011.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2011 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}